zb

Zimmer Biomet

ZBH
NYSE
$93.49

Zimmer Biomet a-t-elle une direction de haute qualité ?

Zimmer Biomet's management shows mixed results. Operational efficiency could be improved, and capital deployment decisions have been inconsistent. The team needs to demonstrate clearer focus on shareholder value creation.